Critical Analysis: Surgery Partners (SGRY) & Its Peers
Surgery Partners (NASDAQ: SGRY) is one of 15 publicly-traded companies in the “Hospitals, Clinics & Primary Care Services” industry, but how does it contrast to its rivals? We will compare Surgery Partners to similar businesses based on the strength of its analyst recommendations, dividends, risk, profitability, valuation, institutional ownership and earnings.
Risk and Volatility
Surgery Partners has a beta of 1.89, suggesting that its stock price is 89% more volatile than the S&P 500. Comparatively, Surgery Partners’ rivals have a beta of 1.47, suggesting that their average stock price is 47% more volatile than the S&P 500.
94.2% of Surgery Partners shares are held by institutional investors. Comparatively, 69.6% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by institutional investors. 7.6% of Surgery Partners shares are held by company insiders. Comparatively, 10.4% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
This table compares Surgery Partners and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Surgery Partners Competitors||3.55%||3.42%||4.26%|
Earnings and Valuation
This table compares Surgery Partners and its rivals revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Surgery Partners||$1.15 billion||$9.45 million||-20.65|
|Surgery Partners Competitors||$1.06 billion||-$22.56 million||765.27|
Surgery Partners has higher revenue and earnings than its rivals. Surgery Partners is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
This is a breakdown of current ratings for Surgery Partners and its rivals, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Surgery Partners Competitors||59||327||512||9||2.52|
Surgery Partners presently has a consensus target price of $18.00, indicating a potential upside of 89.47%. As a group, “Hospitals, Clinics & Primary Care Services” companies have a potential upside of 18.87%. Given Surgery Partners’ higher probable upside, equities analysts plainly believe Surgery Partners is more favorable than its rivals.
Surgery Partners rivals beat Surgery Partners on 8 of the 13 factors compared.
About Surgery Partners
Surgery Partners, Inc. is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services. The Company’s surgical facilities primarily provide non-emergency surgical procedures across a range of specialties, which include gastrointestinal (GI), general surgery, ophthalmology, orthopedics and pain management. The Company’s Ancillary Services segment consists of a diagnostic laboratory, a specialty pharmacy and multi-specialty physician practices. The Company’s physician practices include its owned and operated physician practices pursuant to long-term management service agreements. The Company’s Optical Services segment consists of an optical laboratory, an optical products group purchasing organization.
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.